Cabozantinib in patients with advanced RET-rearranged non-small-cell lung cancer: an open-label, single-centre, phase 2, single-arm trial

Autor: Drilon, Alexander, Rekhtman, Natasha, Arcila, Maria, Wang, Lu, Ni, Andy, Albano, Melanie, Van Voorthuysen, Martine, Somwar, Romel, Smith, Roger S, Montecalvo, Joseph, Plodkowski, Andrew, Ginsberg, Michelle S, Riely, Gregory J, Rudin, Charles M, Ladanyi, Marc, Kris, Mark G
Zdroj: In The Lancet Oncology December 2016 17(12):1653-1660
Databáze: ScienceDirect